CS
IRMD icon

Credit Suisse’s iRadimed IRMD Stock Holding History

Credit Suisse’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$529K Hold
12,031
– – ﹤0.01% 2617
2023
Q4 		$571K Buy
12,031
+6,849
+132% +$288K ﹤0.01% 2665
2023
Q3 		$230K Buy
+5,182
New +$241K ﹤0.01% 2996
2022
Q4 		– Sell
-39
Closed -$1K – 4041
2022
Q3 		$1K Buy
39
+33
+550% +$1.15K ﹤0.01% 3867
2022
Q2 		$0 Buy
+6
New +$215 ﹤0.01% 4118
2016
Q1 		– Sell
-9,948
Closed -$278K – 4139
2015
Q4 		$278K Buy
+9,948
New +$281K ﹤0.01% 3725

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse's IRMD Position: Q1 2024 in Review

Credit Suisse held its iRadimed (IRMD) position steady in Q1 2024 at 12,031 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Credit Suisse first reported a position in IRMD in Q4 2015 and has held it in 6 quarters since. The position peaked at $571K in Q4 2023. 127 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.

  • Credit Suisse held 12,031 shares of iRadimed worth $529K as of Q1 2024.
  • Credit Suisse left its iRadimed share count unchanged in Q1 2024.
  • iRadimed made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2617 holding.
  • Credit Suisse first reported a position in iRadimed in Q4 2015 and has held it in 6 quarters since.
  • Credit Suisse's iRadimed position peaked at $571K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.